Guardant Health
GH
#3237
Rank
S$4.92 B
Marketcap
$39.83
Share price
1.26%
Change (1 day)
29.42%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - P/B ratio

P/B ratio as of November 2024 : -61.1

According to Guardant Health 's latest financial reports the company has a price-to-book ratio of 5.70555.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Guardant Health - P/B ratio (from 2018 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-3120.7-55.31%
2022-12-3146.3193.7%
2021-12-3115.865.85%
2020-12-319.509.84%
2019-12-318.6540.92%
2018-12-316.14
2017-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
20.0-132.68%๐Ÿ‡บ๐Ÿ‡ธ USA
1.06-101.73%๐Ÿ‡บ๐Ÿ‡ธ USA